Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid for Reducing Blood Loss in PAO Surgery
NCT03823417Phase 4Withdrawn
- Sponsor
- Boston Children's Hospital
- Start
- Jul 2019
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial comparing Intravenous Tranexamic acid with Normal saline placebo (2 arms). Primary endpoint: Perioperative Blood Loss at 1 week. Planned start Jul 2019; status: withdrawn.
02
Drugs
tranexamic acid
Beyond the preview
Go deeper on NCT03823417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03823417.